Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have received an average recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year […]
More Stories
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Significant Increase in Short Interest
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large increase in short interest in the...
Rakuten Group, Inc. (OTCMKTS:RKUNY) Sees Significant Growth in Short Interest
Rakuten Group, Inc. (OTCMKTS:RKUNY – Get Free Report) was the recipient of a large growth in short interest in September....
StoneCo Ltd. (NASDAQ:STNE) Short Interest Update
StoneCo Ltd. (NASDAQ:STNE – Get Free Report) saw a large increase in short interest in the month of September. As...
Telesis Bio, Inc. (NASDAQ:TBIO) Sees Significant Growth in Short Interest
Telesis Bio, Inc. (NASDAQ:TBIO – Get Free Report) was the target of a significant increase in short interest during the...
New Research by Candace Owens Casts Doubt on Kamala Harris’s Heritage Claims
By Stephen Zogopoulos, USNN World News In a recent wave of investigative efforts led by Candace Owens, Vice President Kamala...
Kensington Hedged Premium Income ETF (KHPI) to Issue Dividend of $0.19 on October 1st
Kensington Hedged Premium Income ETF (NYSEARCA:KHPI – Get Free Report) announced a dividend on Friday, September 27th, NASDAQ reports. Stockholders...